The Readout Loud

350 Folgen

1. 228: A surprise success in Alzheimer's and how FDA history seeded modern controversy

   Vom: 29.9.2022
2. 227: Biden's Covid declaration, twilight of the SPAC, & genome editing 2.0

   Vom: 22.9.2022
3. 226: Pharma's telehealth gold mine, the return of the biotech IPO, & a merger deferred

   Vom: 15.9.2022
4. 225: Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding

   Vom: 8.9.2022
5. 224: The anti-aging research boom, the Godfather of biotech, & the future of Biogen

   Vom: 1.9.2022
6. 223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO

   Vom: 25.8.2022
7. 222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment

   Vom: 18.8.2022
8. 221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing

   Vom: 11.8.2022
9. 220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble

   Vom: 4.8.2022
10. 219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data

    Vom: 28.7.2022
11. 218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search

    Vom: 21.7.2022
12. 217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'

    Vom: 14.7.2022
13. 216: VC malaise, FDA confusion, & yet another Alzheimer's debate

    Vom: 7.7.2022
14. 215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines

    Vom: 30.6.2022
15. 214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict

    Vom: 23.6.2022
16. 213: How the Fed affects biotech, Paul Offit on vaccines for kids, & another Alzheimer's setback

    Vom: 16.6.2022
17. 212: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy

    Vom: 9.6.2022
18. 211: Biotech's catch-22, a $100 genome, & dealing with monkeypox

    Vom: 2.6.2022
19. 210: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges

    Vom: 26.5.2022
20. Episode 209: Mysterious infections, dwindling Covid funds, & Shkreli out of prison

    Vom: 19.5.2022